SEC Form 4 · accession 0001562180-19-000854
Syndax Pharmaceuticals Inc · SNDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard P Shea
Officer — Chief Financial Officer
Period of report
Feb 6, 2019
Accepted (ET)
Feb 8, 2019 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001395937
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 31, 2019 | J | 2,521 | $4.76 | A | 4,215 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $6.38 | Feb 6, 2019 | A | 91,200 | A | — | Feb 6, 2029 | Common Stock | 91,200 | 91,200 | D |
Explanation of responses
- F1The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 2,521 shares by the Reporting Person on 01/31/2019 pursuant to the Issuer's Employee Stock Purchase Plan.
- F2Includes 1,694 shares cumulatively acquired pursuant to the Issuer's Employee Stock Purchase Plan on 01/31/2018 and 07/31/2018, respectively.
- F3The securities awarded on 02/06/2019 were in the form of stock options issued pursuant to the Syndax Pharmaceuticals, Inc. 2015 Omnibus Incentive Plan. Options to purchase 43,200 shares of common stock shall vest in 48 successive equal monthly installments measured from 02/06/2019. Options to purchase 48,000 shares of common stock shall vest periodically upon the Issuer achieving certain milestones.